We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Inti Landauro PARIS--French pharmaceutical giant Sanofi (SAN.FR) agreed to sell a portfolio of five drugs in Europe to smaller local rival Ipsen (IPN.FR) for 83 million euros ($88 million) to...
Regulatory News: Active Biotech (NASDAQ STOCKHOLM:ACTI) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced top line results of the 10TASQ10 study. While the study showed that...
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Regulatory News : Market : NYSE Euronext ParisISIN Code: FR 0010259150 Date ...
Key steps in thirty month research program underway Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical company, and Hannover Medical School...
Regulatory News: Ipsen (Euronext: IPN, ADR: IPSEY) announced today that it has signed a multi-year research alliance agreement with Harvard University in Cambridge, Mass. Designed...
Organisation du symposium scientifique « Connecting with Creativity » avec des personnalités de premier plan de la science mondiale, notamment des Prix Nobel Regulatory News: Ipsen...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.935 | 6.42857142857 | 30.1 | 32.25 | 30.1 | 1301 | 31.05683689 | DR |
4 | 4.725 | 17.3013548151 | 27.31 | 32.25 | 27.28 | 1061 | 29.2863209 | DR |
12 | 1.035 | 3.33870967742 | 31 | 32.25 | 27.28 | 1253 | 29.11662578 | DR |
26 | 1.585 | 5.2052545156 | 30.45 | 32.25 | 27.11 | 1503 | 29.86385509 | DR |
52 | 3.895 | 13.841506752 | 28.14 | 34.06 | 27 | 1434 | 29.65211308 | DR |
156 | 8.395 | 35.5118443316 | 23.64 | 34.338 | 21.17 | 1370 | 28.46014557 | DR |
260 | 8.985 | 38.9804772234 | 23.05 | 34.338 | 9.1 | 1820 | 24.8250394 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions